Click for best price
Nanotechnology for Healthcare Market Size, Share 2022
It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.
This report contains market size and forecasts of Nanotechnology for Healthcare in Global, including the following market information:
Global Nanotechnology for Healthcare Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Nanotechnology for Healthcare market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nanomedicine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nanotechnology for Healthcare include Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co and Biogen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nanotechnology for Healthcare companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nanotechnology for Healthcare Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Nanotechnology for Healthcare Market Segment Percentages, by Type, 2021 (%)
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Other
Global Nanotechnology for Healthcare Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Nanotechnology for Healthcare Market Segment Percentages, by Application, 2021 (%)
Anticancer
CNS Product
Anti-infective
Other
Global Nanotechnology for Healthcare Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Nanotechnology for Healthcare Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nanotechnology for Healthcare revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Nanotechnology for Healthcare revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Shire
Ipsen
Endo International
| Report Attributes |
Report Details |
| Report Title |
Nanotechnology for Healthcare Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
115 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Nanotechnology for Healthcare Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nanotechnology for Healthcare Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nanotechnology for Healthcare Overall Market Size
2.1 Global Nanotechnology for Healthcare Market Size: 2021 VS 2028
2.2 Global Nanotechnology for Healthcare Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nanotechnology for Healthcare Players in Global Market
3.2 Top Global Nanotechnology for Healthcare Companies Ranked by Revenue
3.3 Global Nanotechnology for Healthcare Revenue by Companies
3.4 Top 3 and Top 5 Nanotechnology for Healthcare Companies in Global Market, by Revenue in 2021
3.5 Global Companies Nanotechnology for Healthcare Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nanotechnology for Healthcare Players in Global Market
3.6.1 List of Global Tier 1 Nanotechnology for Healthcare Companies
3.6.2 List of Global Tier 2 and Tier 3 Nanotechnology for Healthcare Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Nanotechnology for Healthcare Market Size Markets, 2021 & 2028
4.1.2 Nanomedicine
4.1.3 Nano Medical Devices
4.1.4 Nano Diagnosis
4.1.5 Other
4.2 By Type - Global Nanotechnology for Healthcare Revenue & Forecasts
4.2.1 By Type - Global Nanotechnology for Healthcare Revenue, 2017-2022
4.2.2 By Type - Global Nanotechnology for Healthcare Revenue, 2023-2028
4.2.3 By Type - Global Nanotechnology for Healthcare Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nanotechnology for Healthcare Market Size, 2021 & 2028
5.1.2 Anticancer
5.1.3 CNS Product
5.1.4 Anti-infective
5.1.5 Other
5.2 By Application - Global Nanotechnology for Healthcare Revenue & Forecasts
5.2.1 By Application - Global Nanotechnology for Healthcare Revenue, 2017-2022
5.2.2 By Application - Global Nanotechnology for Healthcare Revenue, 2023-2028
5.2.3 By Application - Global Nanotechnology for Healthcare Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Nanotechnology for Healthcare Market Size, 2021 & 2028
6.2 By Region - Global Nanotechnology for Healthcare Revenue & Forecasts
6.2.1 By Region - Global Nanotechnology for Healthcare Revenue, 2017-2022
6.2.2 By Region - Global Nanotechnology for Healthcare Revenue, 2023-2028
6.2.3 By Region - Global Nanotechnology for Healthcare Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Nanotechnology for Healthcare Revenue, 2017-2028
6.3.2 US Nanotechnology for Healthcare Market Size, 2017-2028
6.3.3 Canada Nanotechnology for Healthcare Market Size, 2017-2028
6.3.4 Mexico Nanotechnology for Healthcare Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Nanotechnology for Healthcare Revenue, 2017-2028
6.4.2 Germany Nanotechnology for Healthcare Market Size, 2017-2028
6.4.3 France Nanotechnology for Healthcare Market Size, 2017-2028
6.4.4 U.K. Nanotechnology for Healthcare Market Size, 2017-2028
6.4.5 Italy Nanotechnology for Healthcare Market Size, 2017-2028
6.4.6 Russia Nanotechnology for Healthcare Market Size, 2017-2028
6.4.7 Nordic Countries Nanotechnology for Healthcare Market Size, 2017-2028
6.4.8 Benelux Nanotechnology for Healthcare Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Nanotechnology for Healthcare Revenue, 2017-2028
6.5.2 China Nanotechnology for Healthcare Market Size, 2017-2028
6.5.3 Japan Nanotechnology for Healthcare Market Size, 2017-2028
6.5.4 South Korea Nanotechnology for Healthcare Market Size, 2017-2028
6.5.5 Southeast Asia Nanotechnology for Healthcare Market Size, 2017-2028
6.5.6 India Nanotechnology for Healthcare Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Nanotechnology for Healthcare Revenue, 2017-2028
6.6.2 Brazil Nanotechnology for Healthcare Market Size, 2017-2028
6.6.3 Argentina Nanotechnology for Healthcare Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nanotechnology for Healthcare Revenue, 2017-2028
6.7.2 Turkey Nanotechnology for Healthcare Market Size, 2017-2028
6.7.3 Israel Nanotechnology for Healthcare Market Size, 2017-2028
6.7.4 Saudi Arabia Nanotechnology for Healthcare Market Size, 2017-2028
6.7.5 UAE Nanotechnology for Healthcare Market Size, 2017-2028
7 Players Profiles
7.1 Amgen
7.1.1 Amgen Corporate Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Nanotechnology for Healthcare Major Product Offerings
7.1.4 Amgen Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.1.5 Amgen Key News
7.2 Teva Pharmaceuticals
7.2.1 Teva Pharmaceuticals Corporate Summary
7.2.2 Teva Pharmaceuticals Business Overview
7.2.3 Teva Pharmaceuticals Nanotechnology for Healthcare Major Product Offerings
7.2.4 Teva Pharmaceuticals Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.2.5 Teva Pharmaceuticals Key News
7.3 Abbott
7.3.1 Abbott Corporate Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Nanotechnology for Healthcare Major Product Offerings
7.3.4 Abbott Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.3.5 Abbott Key News
7.4 UCB
7.4.1 UCB Corporate Summary
7.4.2 UCB Business Overview
7.4.3 UCB Nanotechnology for Healthcare Major Product Offerings
7.4.4 UCB Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.4.5 UCB Key News
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Nanotechnology for Healthcare Major Product Offerings
7.5.4 Roche Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.5.5 Roche Key News
7.6 Celgene
7.6.1 Celgene Corporate Summary
7.6.2 Celgene Business Overview
7.6.3 Celgene Nanotechnology for Healthcare Major Product Offerings
7.6.4 Celgene Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.6.5 Celgene Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Nanotechnology for Healthcare Major Product Offerings
7.7.4 Sanofi Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.7.5 Sanofi Key News
7.8 Merck & Co
7.8.1 Merck & Co Corporate Summary
7.8.2 Merck & Co Business Overview
7.8.3 Merck & Co Nanotechnology for Healthcare Major Product Offerings
7.8.4 Merck & Co Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.8.5 Merck & Co Key News
7.9 Biogen
7.9.1 Biogen Corporate Summary
7.9.2 Biogen Business Overview
7.9.3 Biogen Nanotechnology for Healthcare Major Product Offerings
7.9.4 Biogen Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.9.5 Biogen Key News
7.10 Stryker
7.10.1 Stryker Corporate Summary
7.10.2 Stryker Business Overview
7.10.3 Stryker Nanotechnology for Healthcare Major Product Offerings
7.10.4 Stryker Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.10.5 Stryker Key News
7.11 Gilead Sciences
7.11.1 Gilead Sciences Corporate Summary
7.11.2 Gilead Sciences Business Overview
7.11.3 Gilead Sciences Nanotechnology for Healthcare Major Product Offerings
7.11.4 Gilead Sciences Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.11.5 Gilead Sciences Key News
7.12 Pfizer
7.12.1 Pfizer Corporate Summary
7.12.2 Pfizer Business Overview
7.12.3 Pfizer Nanotechnology for Healthcare Major Product Offerings
7.12.4 Pfizer Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.12.5 Pfizer Key News
7.13 3M Company
7.13.1 3M Company Corporate Summary
7.13.2 3M Company Business Overview
7.13.3 3M Company Nanotechnology for Healthcare Major Product Offerings
7.13.4 3M Company Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.13.5 3M Company Key News
7.14 Johnson & Johnson
7.14.1 Johnson & Johnson Corporate Summary
7.14.2 Johnson & Johnson Business Overview
7.14.3 Johnson & Johnson Nanotechnology for Healthcare Major Product Offerings
7.14.4 Johnson & Johnson Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.14.5 Johnson & Johnson Key News
7.15 Smith & Nephew
7.15.1 Smith & Nephew Corporate Summary
7.15.2 Smith & Nephew Business Overview
7.15.3 Smith & Nephew Nanotechnology for Healthcare Major Product Offerings
7.15.4 Smith & Nephew Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.15.5 Smith & Nephew Key News
7.16 Leadiant Biosciences
7.16.1 Leadiant Biosciences Corporate Summary
7.16.2 Leadiant Biosciences Business Overview
7.16.3 Leadiant Biosciences Nanotechnology for Healthcare Major Product Offerings
7.16.4 Leadiant Biosciences Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.16.5 Leadiant Biosciences Key News
7.17 Kyowa Hakko Kirin
7.17.1 Kyowa Hakko Kirin Corporate Summary
7.17.2 Kyowa Hakko Kirin Business Overview
7.17.3 Kyowa Hakko Kirin Nanotechnology for Healthcare Major Product Offerings
7.17.4 Kyowa Hakko Kirin Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.17.5 Kyowa Hakko Kirin Key News
7.18 Shire
7.18.1 Shire Corporate Summary
7.18.2 Shire Business Overview
7.18.3 Shire Nanotechnology for Healthcare Major Product Offerings
7.18.4 Shire Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.18.5 Shire Key News
7.19 Ipsen
7.19.1 Ipsen Corporate Summary
7.19.2 Ipsen Business Overview
7.19.3 Ipsen Nanotechnology for Healthcare Major Product Offerings
7.19.4 Ipsen Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.19.5 Ipsen Key News
7.20 Endo International
7.20.1 Endo International Corporate Summary
7.20.2 Endo International Business Overview
7.20.3 Endo International Nanotechnology for Healthcare Major Product Offerings
7.20.4 Endo International Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.20.5 Endo International Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Nanotechnology for Healthcare Market Opportunities & Trends in Global Market
Table 2. Nanotechnology for Healthcare Market Drivers in Global Market
Table 3. Nanotechnology for Healthcare Market Restraints in Global Market
Table 4. Key Players of Nanotechnology for Healthcare in Global Market
Table 5. Top Nanotechnology for Healthcare Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Nanotechnology for Healthcare Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Nanotechnology for Healthcare Revenue Share by Companies, 2017-2022
Table 8. Global Companies Nanotechnology for Healthcare Product Type
Table 9. List of Global Tier 1 Nanotechnology for Healthcare Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nanotechnology for Healthcare Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Nanotechnology for Healthcare Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Nanotechnology for Healthcare Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Nanotechnology for Healthcare Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Nanotechnology for Healthcare Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Nanotechnology for Healthcare Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Nanotechnology for Healthcare Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Nanotechnology for Healthcare Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Nanotechnology for Healthcare Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Nanotechnology for Healthcare Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Nanotechnology for Healthcare Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Nanotechnology for Healthcare Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Nanotechnology for Healthcare Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Nanotechnology for Healthcare Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Nanotechnology for Healthcare Revenue, (US$, Mn), 2023-2028
Table 30. Amgen Corporate Summary
Table 31. Amgen Nanotechnology for Healthcare Product Offerings
Table 32. Amgen Nanotechnology for Healthcare Revenue (US$, Mn), (2017-2022)
Table 33. Teva Pharmaceuticals Corporate Summary
Table 34. Teva Pharmaceuticals Nanotechnology for Healthcare Product Offerings
Table 35. Teva Pharmaceuticals Nanotechnology for Healthcare Revenue (US$, Mn), (2017-2022)
Table 36. Abbott Corporate Summary
Table 37. Abbott Nanotechnology for Healthcare Product Offerings
Table 38. Abbott Nanotechnology for Healthcare Revenue (US$, Mn), (2017-2022)
Table 39. UCB Corporate Summary
Table 40. UCB Nanotechnology for Healthcare Product Offerings
Table 41. UCB Nanotechnology for Healthcare Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Nanotechnology for Healthcare Product Offerings
Table 44. Roche Nanotechnology for Healthcare Revenue (US$, Mn), (2017-2022)
Table 45. Celgene Corporate Summary
Table 46. Celgene Nanotechnology for Healthcare Product Offerings
Table 47. Celgene Nanotechnology for Healthcare Revenue (US$, Mn), (2017-2022)
Table 48. Sanofi Corporate Summary
Table 49. Sanofi Nanotechnology for Healthcare Product Offerings
Table 50. Sanofi Nanotechnology for Healthcare Revenue (US$, Mn), (2017-2022)
Table 51. Merck & Co Corporate Summary
Table 52. Merck & Co Nanotechnology for Healthcare Product Offerings
Table 53. Merck & Co Nanotechnology for Healthcare Revenue (US$, Mn), (2017-2022)
Table 54. Biogen Corporate Summary
Table 55. Biogen Nanotechnology for Healthcare Product Offerings
Table 56. Biogen Nanotechnology for Healthcare Revenue (US$, Mn), (2017-2022)
Table 57. Stryker Corporate Summary
Table 58. Stryker Nanotechnology for Healthcare Product Offerings
Table 59. Stryker Nanotechnology for Healthcare Revenue (US$, Mn), (2017-2022)
Table 60. Gilead Sciences Corporate Summary
Table 61. Gilead Sciences Nanotechnology for Healthcare Product Offerings
Table 62. Gilead Sciences Nanotechnology for Healthcare Revenue (US$, Mn), (2017-2022)
Table 63. Pfizer Corporate Summary
Table 64. Pfizer Nanotechnology for Healthcare Product Offerings
Table 65. Pfizer Nanotechnology for Healthcare Revenue (US$, Mn), (2017-2022)
Table 66. 3M Company Corporate Summary
Table 67. 3M Company Nanotechnology for Healthcare Product Offerings
Table 68. 3M Company Nanotechnology for Healthcare Revenue (US$, Mn), (2017-2022)
Table 69. Johnson & Johnson Corporate Summary
Table 70. Johnson & Johnson Nanotechnology for Healthcare Product Offerings
Table 71. Johnson & Johnson Nanotechnology for Healthcare Revenue (US$, Mn), (2017-2022)
Table 72. Smith & Nephew Corporate Summary
Table 73. Smith & Nephew Nanotechnology for Healthcare Product Offerings
Table 74. Smith & Nephew Nanotechnology for Healthcare Revenue (US$, Mn), (2017-2022)
Table 75. Leadiant Biosciences Corporate Summary
Table 76. Leadiant Biosciences Nanotechnology for Healthcare Product Offerings
Table 77. Leadiant Biosciences Nanotechnology for Healthcare Revenue (US$, Mn), (2017-2022)
Table 78. Kyowa Hakko Kirin Corporate Summary
Table 79. Kyowa Hakko Kirin Nanotechnology for Healthcare Product Offerings
Table 80. Kyowa Hakko Kirin Nanotechnology for Healthcare Revenue (US$, Mn), (2017-2022)
Table 81. Shire Corporate Summary
Table 82. Shire Nanotechnology for Healthcare Product Offerings
Table 83. Shire Nanotechnology for Healthcare Revenue (US$, Mn), (2017-2022)
Table 84. Ipsen Corporate Summary
Table 85. Ipsen Nanotechnology for Healthcare Product Offerings
Table 86. Ipsen Nanotechnology for Healthcare Revenue (US$, Mn), (2017-2022)
Table 87. Endo International Corporate Summary
Table 88. Endo International Nanotechnology for Healthcare Product Offerings
Table 89. Endo International Nanotechnology for Healthcare Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Nanotechnology for Healthcare Segment by Type in 2021
Figure 2. Nanotechnology for Healthcare Segment by Application in 2021
Figure 3. Global Nanotechnology for Healthcare Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Nanotechnology for Healthcare Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Nanotechnology for Healthcare Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Nanotechnology for Healthcare Revenue in 2021
Figure 8. By Type - Global Nanotechnology for Healthcare Revenue Market Share, 2017-2028
Figure 9. By Application - Global Nanotechnology for Healthcare Revenue Market Share, 2017-2028
Figure 10. By Region - Global Nanotechnology for Healthcare Revenue Market Share, 2017-2028
Figure 11. By Country - North America Nanotechnology for Healthcare Revenue Market Share, 2017-2028
Figure 12. US Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Nanotechnology for Healthcare Revenue Market Share, 2017-2028
Figure 16. Germany Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2028
Figure 17. France Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Nanotechnology for Healthcare Revenue Market Share, 2017-2028
Figure 24. China Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2028
Figure 28. India Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Nanotechnology for Healthcare Revenue Market Share, 2017-2028
Figure 30. Brazil Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Nanotechnology for Healthcare Revenue Market Share, 2017-2028
Figure 33. Turkey Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Nanotechnology for Healthcare Revenue, (US$, Mn), 2017-2028
Figure 37. Amgen Nanotechnology for Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Teva Pharmaceuticals Nanotechnology for Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Abbott Nanotechnology for Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. UCB Nanotechnology for Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Nanotechnology for Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Celgene Nanotechnology for Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sanofi Nanotechnology for Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Merck & Co Nanotechnology for Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Biogen Nanotechnology for Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Stryker Nanotechnology for Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Gilead Sciences Nanotechnology for Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Pfizer Nanotechnology for Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. 3M Company Nanotechnology for Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Johnson & Johnson Nanotechnology for Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Smith & Nephew Nanotechnology for Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Leadiant Biosciences Nanotechnology for Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Kyowa Hakko Kirin Nanotechnology for Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Shire Nanotechnology for Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Ipsen Nanotechnology for Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Endo International Nanotechnology for Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
